Skip to content

Effects of Transcranial Direct Current Stimulation in Refractory Chronic Migraine and Medication-overuse Headache

Randomized Double-Blind Sham-Controlled Study of the Effects of Transcranial Direct Current Stimulation in Refractory Chronic Migraine and Medication-overuse Headache Patients

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01752439
Enrollment
30
Registered
2012-12-19
Start date
2013-02-28
Completion date
2014-03-31
Last updated
2012-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic Migraine, Medication Overuse Headache

Keywords

Chronic Migraine, Medication Overuse Headache, Refractory, transcranial direct current stimulation

Brief summary

The purpose of the study is to evaluate the efficacy of the transcranial direct current stimulation of the primary motor cortex (M1) in patients affected by refractory chronic migraine (coded as 1.5.1 in the international headache classification 2nd edition, 2004) and medication-overuse headache (coded as 8.1) with migraine as primary headache.

Interventions

DEVICESham transcranial direct current stimulation

Sponsors

Dr Armando Perrotta, MD, PhD
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Chronic MIgraine or Medication Overuse Headache according to the diagnostic criteria set out in the 2nd edition of the International Classification of Headache Disorders refractory to treatment according to the Refractory Headache Special Interest Section of the American Headache Society (Schulman et al., 2008)

Exclusion criteria

* Other primary or secondary headaches. * Any serious systemic or neurological disease or psychiatric disorder. * Pregnancy or breastfeeding * Previous or current use of other or similar devices for pain control * Heart conduction and rhythm disorders * Cranial surgery * Other pain conditions, accordingly with current guidelines

Design outcomes

Primary

MeasureTime frame
Change in headache days per monthsat 30, 60 and 90 days after the treatment
Change in drugs intake per monthsat 30, 60 and 90 days after treatment

Secondary

MeasureTime frame
Change in mean pain intensity score per monthsat 30, 60 and 90 days after treatment

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026